| Report ID | 262322 |
| Drug Identification Number | 02242468 |
| Brand name | RIVACOCET |
| Common or Proper name | Rivacocet |
| Company Name | LABORATOIRE RIVA INC. |
| Market Status | MARKETED |
| Active Ingredient(s) | ACETAMINOPHEN OXYCODONE HYDROCHLORIDE |
| Strength(s) | 325MG 5MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL ORAL |
| Packaging size | 100 |
| ATC code | N02AJ |
| ATC description | OPIOIDS |
| Reason for shortage | Demand increase for the drug. |
| Anticipated start date | 2025-08-15 |
| Actual start date | |
| Estimated end date | 2026-01-31 |
| Actual end date | |
| Shortage status | Actual shortage |
| Updated date | 2026-01-05 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 660 BOUL. INDUSTRIEL BLAINVILLE, QUEBEC CANADA J7C 3V4 |
| Company contact information |
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v7 | 2026-01-05 | French | Compare |
| v6 | 2026-01-05 | English | Compare |
| v5 | 2025-09-17 | French | Compare |
| v4 | 2025-09-17 | English | Compare |
| v3 | 2025-08-16 | English | Compare |
| v2 | 2025-07-09 | French | Compare |
| v1 | 2025-07-09 | English | Compare |
Showing 1 to 7 of 7